Combined pharmacotherapy and psychotherapy in the treatment of mild to moderate major depression?

JAMA Psychiatry

Volumn 71, Issue 7, 2014, Pages 747-748

  Cuijpers, Pim ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COMORBIDITY; EFFECT SIZE; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; INTERPERSONAL PSYCHOTHERAPY; MAJOR DEPRESSION; MENTAL DETERIORATION; META ANALYSIS (TOPIC); ORBITAL CORTEX; PATIENT PREFERENCE; PRACTICE GUIDELINE; PSYCHOTHERAPY; SHORT SURVEY; DEPRESSIVE DISORDER, MAJOR; EVIDENCE BASED PRACTICE; MULTIMODALITY CANCER THERAPY; SEVERITY OF ILLNESS INDEX; STANDARDS; TRENDS;

COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY; EVIDENCE-BASED PRACTICE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX;

EID: 84903958524     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.277     Document Type: Short Survey

References (8)

1. Karasu TB, Gelenberg A, Merriam A,Wang P; American Psychiatric Association. Practice Guideline for the Treatment of PatientsWith Major Depressive Disorder. 2nd ed.Washington, DC: American Psychiatric Publishing; 2000.
2. Cuijpers P, SijbrandijM, Koole SL, Andersson G, Beekman AT, Reynolds CF III. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: ameta-analysis.World Psychiatry. 2014;13(1):56-67.
3. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: ameta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
4. Elkin I, Gibbons RD, Shea MT, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995;63(5):841-847.
5. Driessen E, Cuijpers P, Hollon SD, Dekker JJM. Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? Ameta-analysis. J Consult Clin Psychol. 2010;78(5):668-680.
6. Kennedy SH, Konarski JZ, Segal ZV, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry. 2007; 164(5):778-788.
7. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67(12):1265-1273.
8. McHugh RK, Whitton SW, Peckham AD,Welge JA, OttoMW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: ameta-analytic review. J Clin Psychiatry. 2013;74(6):595-602.